Question Bank › The knock on the company is going stale

The knock on the company is going stale

The knock on the company is going stale: this quarter's own facts cut against the standing doubt

Calls Tested
287
Answered YES
68
Hit Rate
23.7%
rare by design

Sonoco Products Company (SON) — this company's answers

NO on the Q4 2015 call 2016-02-11 B
The model's full reasoning — Q4 2015 call → NO我们根据指令分析。需要找出一个明确的、公司特定的疑虑,并且当前期间的实际运营证据要反驳它。从电话会议中,我们看到几个可能的疑虑:工业部门(特别是瓦楞纸介质)的疲软、对客户合同(Irapuato)的依赖、原材料价格波动、以及制造生产力问题。但哪个是“standing doubt”且被当前证据反驳? 一个明显的疑虑是:工业部门(纸和工业转换产品)的持续下滑,以及瓦楞纸介质机器的亏损。管理层承认这是拖累,但表示正在探索解决方案。然而,当前期间(2015年第四季度)的证据显示,工业部门销量下降,EBIT下降,瓦楞纸介质是主要原因。这似乎证实了疑虑,而不是反驳。 另一个疑虑可能是对单一客户(Irapuato)的依赖,但管理层说失去该业务对EBIT影响不大,且是客户决定不续约,这似乎是确认了疑虑(客户离开),但管理层说影响小,这不算反驳。 还有一个疑虑是制造生产力不佳,管理层承认2015年制造生产力未达标,但表示2016年将改善,这是计划而非已发生事实。 再考虑:是否有疑虑是“公司能否持续增长”或“工业部门衰退会拖累整体”?但当前证据显示工业部门确实下滑,所以没有反驳。 或许疑虑是“对原材料价格波动的依赖”,但管理层说价格成本有利,但这是过去的事。 仔细看,有一个疑虑可能是“公司能否在工业疲软下保持盈利”,但当前季度盈利符合预期,但这不是特定疑虑。 另一个可能:疑虑是“公司依赖收购增长”,但当前有有机增长。 实际上,从电话会议中,分析师多次询问工业部门,特别是瓦楞纸介质,管理层承认这是拖累,但说正在解决。这似乎是一个疑虑,但当前证据(第四季度)显示该部门EBIT下降,所以是确认而非反驳。 再读:管理层说“我们预计2016年工业部门会改善”,但这是预测。 或许疑虑是“公司能否维持自由现金流”,但当前现金流强劲。 另一个:疑虑是“公司是否过度依赖少数客户”,但Irapuato事件显示客户离开,但影响小,这不算反驳。 也许疑虑是“公司能否在竞争激烈的包装行业增长”,但当前消费者包装增长强劲,这可能是反驳。 但需要明确一个“standing doubt”在电话会议中被反复提及。我注意到分析师多次问及工业部门,特别是瓦楞纸介质,管理层承认其拖累,但说正在探索选项。这似乎是一个疑虑,但当前证据显示该部门确实下滑,所以没有反驳。 另一个可能:疑虑是“公司能否维持利润率”,但当前利润率有所改善。 再考虑:疑虑是“公司是否过于依赖北美市场”,但国际增长强劲。 实际上,有一个疑虑是“公司能否在原材料价格波动中保持盈利”,但管理层说价格成本有利,但这是过去。 或许疑虑是“公司能否成功整合收购”,但Weidenhammer整合成功,这反驳了疑虑。 但Weidenhammer是收购,不是当前期间运营证据。 我重新阅读:管理层提到“我们2016年展望反映了客户决定不续约Irapuato合同”,这似乎是一个疑虑(客户流失),但管理层说影响小,且是客户决定,这不算反驳。 也许疑虑是“公司能否在工业衰退中保持整体增长”,但当前整体销量增长1.3%,这反驳了。 但工业部门确实下滑,所以整体增长靠其他部门。 我认为最明显的疑虑是“工业部门(特别是瓦楞纸介质)的持续下滑会拖累公司”,但当前证据显示该部门确实下滑,所以是确认。 另一个疑虑可能是“公司能否实现制造生产力目标”,但管理层承认未达标,所以是确认。 因此,可能没有符合的疑虑。 但指令要求“ONE well-defined DOUBT”且“current period's own operating evidence moves clearly AGAINST that doubt”。也许疑虑是“公司能否在消费者包装领域持续增长”,但当前消费者包装增长强劲,这反驳了。 但消费者包装增长是事实,且管理层详细描述了增长来源(flexibles等),这可能是反驳。 然而,这个疑虑是否“standing”?分析师没有明确质疑消费者包装,而是质疑工业。 再考虑:疑虑是“公司是否过度依赖单一客户”,但Irapuato事件显示客户离开,但影响小,这不算反驳。 也许疑虑是“公司能否在竞争激烈的市场中保持份额”,但当前有增长。 我决定:没有明确的疑虑被当前证据反驳。因为工业部门下滑是事实,且管理层没有用当前证据反驳,而是承认并计划未来改善。 因此,答案应为NO。 但让我们再确认:是否有任何疑虑被当前证据反驳?例如,疑虑是“公司能否维持自由现金流”,但当前现金流强劲,这反驳了。但这是否是“standing doubt”?分析师没有特别问。 另一个:疑虑是“公司能否在原材料价格下跌中保持盈利”,但当前盈利符合预期,这反驳了。 但这不是公司特定。 我认为最接近的是“工业部门衰退会持续”,但当前证据显示下滑,所以没有反驳。 因此,答案NO。

← Back to the full SON analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: Reading this call as a whole, can you identify ONE well-defined DOUBT that has clearly been weighing on how this company is perceived — a standing knock evident from the transcript itself, such as skepticism that its losses will ever end, that its main product or model will find repeat demand, that its legacy business's decline will swamp everything else, that it depends too heavily on one customer, market, or financing source, or another comparable company-specific concern — AND does the CURRENT PERIOD'S OWN OPERATING EVIDENCE, as recounted by management, move clearly AGAINST that doubt? Answer YES when BOTH halves come through in the transcript, in whatever form fits the business: (1) A STANDING, COMPANY-SPECIFIC DOUBT IS VISIBLE ON THE CALL. The transcript itself shows that a particular concern has hung over this company — through analysts returning to it, management acknowledging what skeptics or investors have worried about, or management plainly addressing a question it knows the audience carries (can this business make money, will anyone buy this at scale, will the decline stop, can they fund themselves, will the big customer stay). The doubt must be specific to this company's situation, not generic macro gloom, and must read as something that predates this quarter rather than arising on this call. (2) THIS PERIOD'S REAL ACTIVITY CUTS AGAINST IT. Management recounts concrete things that actually happened in the recent period — actual orders, customers returning or expanding, real revenue or volumes where there had been little, losses narrowing because of how the business itself is now running, the doubted product performing in real use, the feared departure or decline not occurring while something better did — described with enough operating substance that the contradiction rests on observed events rather than on reassurance, plans, or projections. The evidence need not fully settle the doubt; what matters is that the current period's facts point the other way and management engages the doubt with those facts. Answer NO if no company-specific doubt is discernible — an ordinarily healthy company reporting a routine quarter. NO if the doubt exists but management answers it mainly with confidence, vision, targets, or hoped-for improvements rather than with things that already happened. NO if the period's evidence actually confirms the doubt (the losses widened, the decline continued, the customer left) and management is excusing it. NO if the contrary evidence is a one-time item, an asset sale, a financing, or something management itself treats as non-recurring rather than the business operating differently. NO if the doubt and the evidence never connect — strong facts reported on one topic while the standing concern sits elsewhere untouched. NO if the doubt appears only as boilerplate risk language or an analyst aside that management never engages. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
CRGO Freightos Limited Q1 2024 2024-05-20 C+
IFS Intercorp Financial Services Inc. Q1 2024 2024-05-14 C+
PRA ProAssurance Corporation Q1 2024 2024-05-11 D
LTRX Lantronix, Inc. Q3 2024 2024-04-29 C
ASB Associated Banc-Corp Q1 2024 2024-04-25 A
GL Globe Life Inc. Q1 2024 2024-04-23 F
ASM Avino Silver & Gold Mines Ltd. Q4 2023 2024-03-21 C+
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
HP Helmerich & Payne, Inc. Q1 2024 2024-01-30 C
PFE Pfizer Inc. Q4 2023 2024-01-30 F
QTRX Quanterix Corporation Q3 2023 2023-11-07 B
ALL The Allstate Corporation Q3 2023 2023-11-02 C+
DASH DoorDash, Inc. Q3 2023 2023-11-01 C+
PTN Palatin Technologies, Inc. Q4 2023 2023-09-29 D
BZUN Baozun Inc. Q2 2023 2023-08-28 D
GVP GSE Systems, Inc. Q1 2023 2023-05-15 D
BXSL Blackstone Secured Lending Fund Q1 2023 2023-05-10 A
FTHM Fathom Holdings, Inc. Q1 2023 2023-05-10 C
SPIR Spire Global, Inc. Q1 2023 2023-05-10 B
SBRA Sabra Health Care REIT, Inc. Q1 2023 2023-05-04 B
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
VRE Veris Residential, Inc. Q4 2022 2023-02-22 D
TOST Toast, Inc. Q4 2022 2023-02-16 C+
PKOH Park-Ohio Holdings Corp. Q3 2022 2022-11-13 B
CLSD Clearside Biomedical, Inc. Q3 2022 2022-11-09 C
SIBN SI-BONE, Inc. Q3 2022 2022-11-07 C+
CHE Chemed Corporation Q3 2022 2022-11-01 B+
YMM Full Truck Alliance Co. Ltd. Q2 2022 2022-08-25 C+
EXFY Expensify, Inc. Q2 2022 2022-08-12 D
WD Walker & Dunlop, Inc. Q2 2022 2022-08-09 C+
DM Desktop Metal, Inc. Q2 2022 2022-08-08 F
XHR Xenia Hotels & Resorts, Inc. Q2 2022 2022-08-05 A
LIN Linde plc Q2 2022 2022-07-28 B+
CME CME Group Inc. Q2 2022 2022-07-27 B
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
SE Sea Limited Q1 2022 2022-05-17 F
VNRX VolitionRx Limited Q1 2022 2022-05-12 F
OPK OPKO Health, Inc. Q1 2022 2022-05-09 D
FARM Farmer Bros. Co. Q3 2022 2022-05-07 D
BFIN BankFinancial Corporation Q1 2022 2022-05-06 A
BXP Boston Properties, Inc. Q1 2022 2022-05-03 A
STC Stewart Information Services Corporation Q1 2022 2022-04-29 C+
LOW Lowe's Companies, Inc. Q3 2021 2021-11-17 B+
CYBR CyberArk Software Ltd. Q3 2021 2021-11-04 B+
IPGP IPG Photonics Corporation Q3 2021 2021-11-02 C
SXC SunCoke Energy, Inc. Q3 2021 2021-11-01 A
EMR Emerson Electric Co. Q3 2021 2021-08-04 B+
EEX Emerald Holding, Inc. Q2 2021 2021-08-01 C+
GECC Great Elm Capital Corporation Q3 2018 2018-11-13 B
UMH UMH Properties, Inc. Q3 2018 2018-11-02 C+
FOSL Fossil Group, Inc. Q1 2018 2018-05-08 C
BCOV Brightcove Inc. Q1 2018 2018-04-26 B+
AVT Avnet, Inc. Q2 2018 2018-01-25 B
PII Polaris Inc. Q3 2017 2017-10-24 C+
GNTX Gentex Corporation Q3 2017 2017-10-20 B
MTG MGIC Investment Corporation Q3 2017 2017-10-18 B+
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C
BIIB Biogen Inc. Q2 2017 2017-07-25 B
CAG Conagra Brands, Inc. Q2 2017 2016-12-22 C+
WYY WidePoint Corporation Q3 2016 2016-11-09 D
ULBI Ultralife Corporation Q3 2016 2016-10-29 C+
ARAY Accuray Incorporated Q4 2016 2016-08-17 B
GES Guess?, Inc. Q1 2017 2016-05-25 F
RCL Royal Caribbean Cruises Ltd. Q1 2016 2016-04-29 C+
DD DuPont de Nemours, Inc. Q1 2016 2016-04-26 B+
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C

How the model reasoned

BRX · Q1 2023 → YESThe question asks if there's a standing company-specific doubt visible on the call, and if this period's operating evidence cuts against it. YES The standing doubt is the skepticism that tenant disruptions (especially bankruptcies like Bed Bath) will create occupancy pressure and throw markets out of equilibrium, given the recaptured space and potential for more filings. This is visible in analyst questions (Todd Thomas on Bed Bath impact and market equilibrium; others circling back on bad debt 75-110 bps and bankruptcy activity) and management's acknowledgment that "recent retailer bankruptcy announcements will result in occupancy pressure" while noting they've "been preparing for the last several quarters." This period's evidence cuts against it: record 94% total occupancy (up sequentially in a seasonally weak quarter), small-shop at 89.
CME · Q2 2022 → YESThe question is: Identify ONE well-defined DOUBT that has been weighing on the company, and see if the current period's operating evidence moves against that doubt. YES The standing doubt is the perceived risk that the legacy NEX Group businesses (BrokerTec and EBS) would continue to show range-bound revenue and fail to deliver meaningful growth despite a constructive macro backdrop, as directly raised by Alex Blostein. Management engages this concern head-on by recounting concrete operating evidence from 2Q: BrokerTec US treasuries ADV up 14% YoY, US repo up 25% YoY, EU repo up 14% YoY, plus $4.5 billion in new cross-sell volume from previously non-trading clients and record RV trading volumes of $2.4 billion; 90% of the migration to Globex is complete, with the remaining EBS migration also finished and system enhancements underway.
BXSL · Q1 2023 → YESThe question asks if there's a standing company-specific doubt visible in the transcript, and if this period's operating evidence moves against it. YES The standing doubt visible in the transcript is the skepticism that BXSL’s credit performance will be materially worse than the broader private-credit market because of its exposure to higher-rate environments and the “tails” of the portfolio (i.e., the small slice of companies whose interest-coverage ratios could fall below 1× when 5 % rates are stress-tested). Management itself flags this concern by noting that “it is less about averages… much more about the tails” and that investors keep asking about the percentage of the portfolio below 1× ICR. This quarter’s operating evidence directly counters that doubt: - 0.

More from the question bank

Acted like it's already biggerBetting on a claim they haven't proven yetMoney already collected for work not yet donNew faces on the callThe streak is aliveCommitted past the numbersAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.